Does EVOLOCUMAB Cause Sinusitis? 586 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 586 reports of Sinusitis have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.4% of all adverse event reports for EVOLOCUMAB.
586
Reports of Sinusitis with EVOLOCUMAB
0.4%
of all EVOLOCUMAB reports
2
Deaths
33
Hospitalizations
How Dangerous Is Sinusitis From EVOLOCUMAB?
Of the 586 reports, 2 (0.3%) resulted in death, 33 (5.6%) required hospitalization.
Is Sinusitis Listed in the Official Label?
Yes, Sinusitis is listed as a known adverse reaction in the official FDA drug label for EVOLOCUMAB.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Sinusitis?
ETANERCEPT (9,620)
ADALIMUMAB (9,283)
METHOTREXATE (6,115)
ABATACEPT (5,458)
TOFACITINIB (5,422)
TOCILIZUMAB (5,271)
CERTOLIZUMAB PEGOL (4,997)
RITUXIMAB (4,659)
GOLIMUMAB (4,471)
HUMAN IMMUNOGLOBULIN G (4,409)
Which EVOLOCUMAB Alternatives Have Lower Sinusitis Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE